Resection and advancement of esophageal mucosa
- 45 Downloads
- 6 Citations
Abstract
Background
Barrett’s esophagus affects 5–10% of patients with gastroesophageal reflux disease (GERD) and is associated with a 40-fold increased risk of malignant transformation. Ablative therapies may lead to esophageal perforation or stricture formation if applied too liberally and residual glandular tissue and persistent cancer risk if utilized too sparingly.
Methods
Ten pigs underwent gastrotomy. Mucosa below the gastroesophageal (GE) junction was elevated by saline injections, circumferentially incised, and secured to an orogastric tube. By traction, the distal esophageal mucosa was inverted 10 cm proximally, then returned to the gastric lumen. In group A (n=4), the mucosa (5 cm) was resected and the remnant was allowed to retract. In group B (n=4), the mucosa was simply sutured back into its native position. In group C (n=2), the mucosa (5 cm) was resected and the proximal segment was advanced and sutured to the gastric mucosa. At 6 weeks, or sooner if stricture developed, the animals were killed. Stricture formation was determined by ex vivo barium esophagram and gross assessment. The extent of fibrosis and epithelial healing were established histologically.
Results
Group A (mucosa resected) developed weight loss and anorexia within 4 weeks. Pathology revealed dense fibrotic stricture without reepithelialization. Group B (mucosa elevated/replaced) gained weight after the operation. Histology demonstrated mucosal healing without significant stricture or fibrosis. Group C (mucosa resected/advanced) also thrived postoperatively. Histology confirmed mucosal healing without evidence of retraction or dense stricture.
Conclusions
Exposure of submucosal tissues causes esophageal stricture. Mucosal coverage minimizes submucosal fibrosis after injury. Mucosal resection and advancement allows healing without stricture and may have therapeutic potential for patients with Barrett’s esophagus.
Key words
Barrett’s esophagus Metaplasia Gastroesophageal reflux disease Mucosal resection Esophageal mucosa Stricture Fibrosis Porcine modelPreview
Unable to display preview. Download preview PDF.
References
- 1.Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS (1993) Restoration of squamous mucosa after ablation of Barrett’s esophaeal epithelium. Gastroenterology 104: 1686–1691PubMedGoogle Scholar
- 2.Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR (1994) Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg 129: 609–614PubMedGoogle Scholar
- 3.Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, Henrich R, Vieth M, Muller H, Seitz G, Stolte M (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118: 670–677PubMedCrossRefGoogle Scholar
- 4.Inoue H, Endo M (1990) Endoscopic esophageal mucosal resection using a transparent tube. Surg Endosc 4: 198–201PubMedCrossRefGoogle Scholar
- 5.Inoue M, Shiozaki H, Tamura S, Monden M (1996) Endoscopic mucosal resection for early esophageal cancer. Nippon-Rinsho-Japanese J Clin Med 54: 1286–1291Google Scholar
- 6.Jennings RW, Flake AW, Mussan G, Harrison MR, Adzick NS, Pelligrini CA (1992) A novel endoscopic transgastric fundoplication procedure for gastreosophageal reflux: an initial animal evaluation. J Laparoendosc Surg 2: 207–213PubMedGoogle Scholar
- 7.Kahrilas PJ (1996) Gastroesophageal reflux disease. JAMA 276: 983–988PubMedCrossRefGoogle Scholar
- 8.Makuuchi H (1996) Esophageal endoscopic mucosal resection (EEMR) tube. Surg Laparosc Endosc 6: 160–161PubMedCrossRefGoogle Scholar
- 9.Moreira LF, Kamikawa Y, Naomoto Y, Haisa M, Orita K (1995) Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc 5: 171–175PubMedGoogle Scholar
- 10.Overholt BF, Panjehpour M, Haydek JM (1999) Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 49: 1–7PubMedCrossRefGoogle Scholar
- 11.Richardson WS, Trus TL, Thompson S, Hunter JG (1997) Nissen and Toupet fundoplications effectively inhibit gastroesophageal reflux irrespective of natural anatomy and function. Surg Endosc 11: 261–263PubMedCrossRefGoogle Scholar
- 12.Sampliner RE (1997) New treatments for Barrett’s esophagus. Semin Gastrointest Dis 8: 68–74PubMedGoogle Scholar
- 13.Sampliner RE, Hixson LJ, Fennerty MB, Garewal HS (1993) Regression of Barrett’s esophagus by laser ablation in an antacid environment. Dig Dis Sci 38: 365–368PubMedCrossRefGoogle Scholar
- 14.Spechler SJ, Goyal RK (1986) Barrett’s esophagus. N Engl J Med 315: 362–371PubMedGoogle Scholar